| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.75e-10 | 43 | 121 | 8 | GO:0030280 | |
| GeneOntologyMolecularFunction | structural molecule activity | TPR KRT4 KRT6A KRT6B EPPK1 MAP1B SYNM KRT81 KRT83 KRT84 KRT86 SPTA1 NPHP4 OGN COL18A1 KRT6C CROCC MYBPC2 | 6.94e-06 | 891 | 121 | 18 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 1.44e-05 | 130 | 121 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | protein-membrane adaptor activity | 1.58e-04 | 45 | 121 | 4 | GO:0043495 | |
| GeneOntologyMolecularFunction | actin binding | MAP1B SYNE1 SPTA1 MYRIP INO80 FMNL3 XIRP2 SYNE2 AFDN CROCC MYBPC2 | 1.61e-04 | 479 | 121 | 11 | GO:0003779 |
| GeneOntologyMolecularFunction | stalled ribosome sensor activity | 2.17e-04 | 4 | 121 | 2 | GO:0170011 | |
| GeneOntologyMolecularFunction | cytoskeleton-nuclear membrane anchor activity | 3.60e-04 | 5 | 121 | 2 | GO:0140444 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TPR SYNM SYNE1 XPC ATG2A DDX5 NLRP6 TCERG1 AP2B1 SYNE2 GNB5 RBM14 MED12L TRAF3IP3 ZNF598 RPA1 SPEN | 6.26e-04 | 1160 | 121 | 17 | GO:0030674 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | TPR MAP1B SYNM SYNE1 SPTA1 MYRIP INO80 FMNL3 XIRP2 SYNE2 AFDN CROCC HSPA2 RAB27A DNM2 MYBPC2 | 9.80e-04 | 1099 | 121 | 16 | GO:0008092 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 3.06e-10 | 99 | 120 | 10 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 3.38e-10 | 100 | 120 | 10 | GO:0045103 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 5.13e-10 | 75 | 120 | 9 | GO:0045109 | |
| GeneOntologyBiologicalProcess | keratinization | 4.13e-08 | 87 | 120 | 8 | GO:0031424 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | KRT4 KRT6A KRT6B EPPK1 PLOD3 MAP1B BRK1 KRT81 KRT83 KRT84 KRT86 SPTA1 PLEKHG2 COL18A1 KRT6C XIRP2 DYNC1H1 FCHSD1 DNM2 MYBPC2 | 6.32e-07 | 957 | 120 | 20 | GO:0097435 |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 1.50e-05 | 189 | 120 | 8 | GO:0030216 | |
| GeneOntologyBiologicalProcess | organelle assembly | TPR TBC1D15 MOSPD2 SYNE1 E2F4 ARMC9 INO80 ODAD2 ATG2A DICER1 AP1B1 SYNE2 RBM14 ASPM UHRF1 CROCC DYNC1H1 DNM2 MYBPC2 | 3.07e-05 | 1138 | 120 | 19 | GO:0070925 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 3.87e-05 | 280 | 120 | 9 | GO:1902115 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | KRT4 KRT6A KRT6B EPPK1 PLOD3 MAP1B KRT81 KRT83 KRT84 KRT86 E2F4 DICER1 COL18A1 PELO KRT6C AFDN | 4.47e-05 | 870 | 120 | 16 | GO:0030855 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | EPHB3 TPR TBC1D15 MAP1B BRK1 SYNE1 SPTA1 PLEKHG2 ATG2A NPHP4 SYNE2 RBM14 AFDN CROCC HSPA2 DYNC1H1 JAM3 FCHSD1 DNM2 | 5.56e-05 | 1189 | 120 | 19 | GO:0044087 |
| GeneOntologyBiologicalProcess | skin development | 6.60e-05 | 373 | 120 | 10 | GO:0043588 | |
| GeneOntologyBiologicalProcess | nuclear matrix organization | 2.00e-04 | 4 | 120 | 2 | GO:0043578 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 2.60e-04 | 284 | 120 | 8 | GO:0009913 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | TPR TBC1D15 EID3 MAP1B BRK1 SYNE1 SPTA1 PLEKHG2 INO80 ATG2A XIRP2 SYNE2 RBM14 EIF2AK1 CROCC DYNC1H1 JAM3 FCHSD1 DNM2 | 2.69e-04 | 1342 | 120 | 19 | GO:0033043 |
| GeneOntologyBiologicalProcess | spindle assembly | 2.75e-04 | 153 | 120 | 6 | GO:0051225 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TPR MAP1B E2F4 INO80 ODAD2 DICER1 SYNE2 RBM14 ASPM UHRF1 CROCC DYNC1H1 DNM2 | 2.90e-04 | 720 | 120 | 13 | GO:0000226 |
| GeneOntologyBiologicalProcess | regulation of mini excitatory postsynaptic potential | 3.32e-04 | 5 | 120 | 2 | GO:0061884 | |
| GeneOntologyBiologicalProcess | mini excitatory postsynaptic potential | 3.32e-04 | 5 | 120 | 2 | GO:0098816 | |
| GeneOntologyBiologicalProcess | negative regulation of translational initiation | 3.56e-04 | 24 | 120 | 3 | GO:0045947 | |
| GeneOntologyBiologicalProcess | epidermis development | 3.66e-04 | 461 | 120 | 10 | GO:0008544 | |
| GeneOntologyBiologicalProcess | regulation of cilium assembly | 4.24e-04 | 108 | 120 | 5 | GO:1902017 | |
| GeneOntologyCellularComponent | keratin filament | 4.34e-09 | 97 | 119 | 9 | GO:0045095 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT4 KRT6A KRT6B EPPK1 SYNM KRT81 KRT83 KRT84 KRT86 KRT6C SYNE2 | 3.23e-07 | 263 | 119 | 11 | GO:0045111 |
| GeneOntologyCellularComponent | intermediate filament | 7.09e-07 | 227 | 119 | 10 | GO:0005882 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT4 KRT6A KRT6B EPPK1 MAP1B SYNM KRT81 KRT83 SYNE1 KRT84 KRT86 INO80 KRT6C XIRP2 SYNE2 ASPM DYNC1H1 JAM3 DNM2 MYBPC2 | 1.06e-05 | 1179 | 119 | 20 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT4 KRT6A KRT6B EPPK1 MAP1B SYNM KRT81 KRT83 SYNE1 KRT84 KRT86 INO80 KRT6C XIRP2 SYNE2 ASPM DYNC1H1 JAM3 DNM2 MYBPC2 | 1.17e-05 | 1187 | 119 | 20 | GO:0099081 |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT4 KRT6A KRT6B EPPK1 MAP1B SYNM KRT81 KRT83 KRT84 KRT86 INO80 KRT6C ASPM DYNC1H1 JAM3 DNM2 | 5.08e-05 | 899 | 119 | 16 | GO:0099513 |
| GeneOntologyCellularComponent | endoplasmic reticulum-endosome membrane contact site | 1.91e-04 | 4 | 119 | 2 | GO:0140284 | |
| HumanPheno | Perifollicular hyperkeratosis | 2.74e-06 | 4 | 46 | 3 | HP:0007468 | |
| HumanPheno | White lesion of the oral mucosa | 4.04e-06 | 28 | 46 | 5 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 4.04e-06 | 28 | 46 | 5 | HP:0002745 | |
| HumanPheno | Follicular hyperkeratosis | 5.79e-06 | 30 | 46 | 5 | HP:0007502 | |
| HumanPheno | Abnormal perifollicular morphology | 1.35e-05 | 6 | 46 | 3 | HP:0031285 | |
| HumanPheno | Epidermal thickening | KRT6A KRT6B KRT81 KRT83 SYNE1 KRT86 PEPD XPC PIGA AP1B1 KRT6C SYNE2 | 9.22e-05 | 379 | 46 | 12 | HP:0011368 |
| HumanPheno | Ventricular escape rhythm | 1.08e-04 | 11 | 46 | 3 | HP:0005155 | |
| HumanPheno | Proximal upper limb amyotrophy | 1.85e-04 | 13 | 46 | 3 | HP:0008948 | |
| HumanPheno | Regional abnormality of skin | KRT6A KRT6B CCDC22 PLOD3 MAP1B PDHA1 KRT83 PEPD POLRMT XPC PIGA AP1B1 KRT6C MED12L | 1.88e-04 | 541 | 46 | 14 | HP:0011356 |
| HumanPheno | Hyperkeratosis | 1.88e-04 | 233 | 46 | 9 | HP:0000962 | |
| HumanPheno | Abnormality of the musculature of the upper arm | 2.34e-04 | 14 | 46 | 3 | HP:0001457 | |
| Domain | Keratin_II | 3.04e-12 | 26 | 119 | 8 | IPR003054 | |
| Domain | Keratin_2_head | 1.13e-10 | 24 | 119 | 7 | IPR032444 | |
| Domain | Keratin_2_head | 1.13e-10 | 24 | 119 | 7 | PF16208 | |
| Domain | Intermediate_filament_CS | 2.26e-10 | 63 | 119 | 9 | IPR018039 | |
| Domain | IF | 7.74e-10 | 72 | 119 | 9 | PS00226 | |
| Domain | Filament | 8.79e-10 | 73 | 119 | 9 | PF00038 | |
| Domain | IF | 1.27e-09 | 76 | 119 | 9 | IPR001664 | |
| Domain | Filament | 1.63e-08 | 71 | 119 | 8 | SM01391 | |
| Domain | Beta2_adaptin/TBP_C_dom | 4.97e-06 | 6 | 119 | 3 | IPR012295 | |
| Domain | - | 4.97e-06 | 6 | 119 | 3 | 3.30.310.10 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 4.03e-05 | 2 | 119 | 2 | IPR013037 | |
| Domain | - | 4.03e-05 | 2 | 119 | 2 | 2.60.40.1150 | |
| Domain | AP_complex_bsu_1_2_4 | 1.20e-04 | 3 | 119 | 2 | IPR016342 | |
| Domain | B2-adapt-app_C | 1.20e-04 | 3 | 119 | 2 | PF09066 | |
| Domain | KASH | 2.40e-04 | 4 | 119 | 2 | IPR012315 | |
| Domain | KASH | 2.40e-04 | 4 | 119 | 2 | PS51049 | |
| Domain | B2-adapt-app_C | 2.40e-04 | 4 | 119 | 2 | SM01020 | |
| Domain | KASH | 2.40e-04 | 4 | 119 | 2 | SM01249 | |
| Domain | KASH | 2.40e-04 | 4 | 119 | 2 | PF10541 | |
| Domain | B-adaptin_app_sub_C | 2.40e-04 | 4 | 119 | 2 | IPR015151 | |
| Domain | AP_beta | 3.98e-04 | 5 | 119 | 2 | IPR026739 | |
| Domain | Spectrin | 4.07e-04 | 23 | 119 | 3 | PF00435 | |
| Domain | E2F_CC-MB | 5.94e-04 | 6 | 119 | 2 | IPR032198 | |
| Domain | E1_dh | 5.94e-04 | 6 | 119 | 2 | PF00676 | |
| Domain | DH_E1 | 5.94e-04 | 6 | 119 | 2 | IPR001017 | |
| Domain | E2F_CC-MB | 5.94e-04 | 6 | 119 | 2 | PF16421 | |
| Domain | Spectrin_repeat | 8.17e-04 | 29 | 119 | 3 | IPR002017 | |
| Domain | SPEC | 1.09e-03 | 32 | 119 | 3 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.09e-03 | 32 | 119 | 3 | IPR018159 | |
| Domain | E2F | 1.10e-03 | 8 | 119 | 2 | IPR015633 | |
| Domain | Coatomer/calthrin_app_sub_C | 1.10e-03 | 8 | 119 | 2 | IPR009028 | |
| Domain | Alpha_adaptinC2 | 1.41e-03 | 9 | 119 | 2 | PF02883 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 1.41e-03 | 9 | 119 | 2 | IPR008152 | |
| Domain | Alpha_adaptinC2 | 1.41e-03 | 9 | 119 | 2 | SM00809 | |
| Domain | ARM-like | 1.73e-03 | 270 | 119 | 7 | IPR011989 | |
| Domain | ARM | 2.10e-03 | 40 | 119 | 3 | SM00185 | |
| Domain | E2F_TDP | 2.13e-03 | 11 | 119 | 2 | PF02319 | |
| Domain | E2F_TDP | 2.13e-03 | 11 | 119 | 2 | SM01372 | |
| Domain | E2F_WHTH_DNA-bd_dom | 2.13e-03 | 11 | 119 | 2 | IPR003316 | |
| Domain | Coatomer/clathrin_app_Ig-like | 2.55e-03 | 12 | 119 | 2 | IPR013041 | |
| Domain | THDP-binding | 3.00e-03 | 13 | 119 | 2 | IPR029061 | |
| Domain | - | 3.00e-03 | 13 | 119 | 2 | 3.40.50.970 | |
| Domain | - | 3.00e-03 | 222 | 119 | 6 | 1.25.10.10 | |
| Domain | Armadillo | 3.33e-03 | 47 | 119 | 3 | IPR000225 | |
| Domain | RECEPTOR_TYR_KIN_V_2 | 3.48e-03 | 14 | 119 | 2 | PS00791 | |
| Domain | RECEPTOR_TYR_KIN_V_1 | 3.48e-03 | 14 | 119 | 2 | PS00790 | |
| Domain | Tyr_kinase_rcpt_V_CS | 3.48e-03 | 14 | 119 | 2 | IPR001426 | |
| Domain | EphA2_TM | 3.48e-03 | 14 | 119 | 2 | PF14575 | |
| Domain | Ephrin_rcpt_lig-bd_dom | 3.48e-03 | 14 | 119 | 2 | IPR001090 | |
| Domain | Eph_TM | 3.48e-03 | 14 | 119 | 2 | IPR027936 | |
| Domain | EPH_lbd | 3.48e-03 | 14 | 119 | 2 | SM00615 | |
| Domain | Ephrin_lbd | 3.48e-03 | 14 | 119 | 2 | PF01404 | |
| Domain | Tyr_kinase_ephrin_rcpt | 3.48e-03 | 14 | 119 | 2 | IPR016257 | |
| Domain | EPH_LBD | 3.48e-03 | 14 | 119 | 2 | PS51550 | |
| Domain | Clathrin/coatomer_adapt-like_N | 4.00e-03 | 15 | 119 | 2 | IPR002553 | |
| Domain | Adaptin_N | 4.00e-03 | 15 | 119 | 2 | PF01602 | |
| Domain | Helicase_C | 4.88e-03 | 107 | 119 | 4 | PF00271 | |
| Domain | HELICc | 4.88e-03 | 107 | 119 | 4 | SM00490 | |
| Domain | Helicase_C | 5.05e-03 | 108 | 119 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 5.21e-03 | 109 | 119 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 5.21e-03 | 109 | 119 | 4 | PS51192 | |
| Domain | DEXDc | 5.21e-03 | 109 | 119 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 5.38e-03 | 110 | 119 | 4 | IPR014001 | |
| Domain | ARM-type_fold | 6.04e-03 | 339 | 119 | 7 | IPR016024 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | EPHB3 KRT4 KRT6A KRT6B KRT81 KRT83 KRT84 KRT86 SPTA1 MYRIP AP2B1 NGEF RAB27A DNM2 EPHA4 | 1.60e-06 | 502 | 97 | 15 | MM14537 |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.19e-06 | 87 | 97 | 7 | MM15351 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.89e-06 | 129 | 97 | 8 | M27649 | |
| Pathway | REACTOME_KERATINIZATION | 8.78e-05 | 153 | 97 | 7 | MM15343 | |
| Pathway | REACTOME_KERATINIZATION | 1.24e-04 | 217 | 97 | 8 | M27640 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | TPR KRT6A CPNE8 TBC1D15 EPPK1 MAP1B SYNE1 KRT84 KRT86 EXOC3 DICER1 DDX5 PDIA4 CRNKL1 KRT6C SYNE2 RBM14 UBA6 UHRF1 AFDN RPA1 SPEN DYNC1H1 HDLBP | 1.51e-13 | 1024 | 122 | 24 | 24711643 |
| Pubmed | KRT4 KRT6A KRT6B KRT81 KRT83 KRT84 KRT86 SPTA1 DDX5 AP1B1 KRT6C AP2B1 DYNC1H1 DNM2 | 6.82e-13 | 266 | 122 | 14 | 19380743 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | TPR KRT4 KRT6A KRT6B CPNE8 EPPK1 PLOD3 SYNM KRT84 POLRMT OAS3 RECQL DDX5 EIF3CL CRNKL1 TCERG1 AP2B1 DNAJC11 EIF2B4 RBM14 ZNF598 SPEN DYNC1H1 HDLBP | 1.14e-11 | 1257 | 122 | 24 | 36526897 |
| Pubmed | Hague (Hag). A new mouse hair mutation with an unstable semidominant allele. | 1.28e-11 | 16 | 122 | 6 | 12399393 | |
| Pubmed | TPR EPPK1 MAP1B PDHA1 POLRMT RECQL DICER1 PDIA4 CRNKL1 AP1B1 AP2B1 SYNE2 AFDN SPEN HSPA2 DYNC1H1 DNM2 HDLBP | 1.63e-11 | 653 | 122 | 18 | 22586326 | |
| Pubmed | 5.99e-11 | 63 | 122 | 8 | 16831889 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TPR TBC1D15 PDHA1 SYNE1 RBM26 PEPD POLRMT RECQL DICER1 DDX5 EIF3CL PDIA4 CRNKL1 TCERG1 DNAJC11 RBM14 UBA6 UHRF1 AFDN RPA1 SPEN DYNC1H1 HDLBP NPAS2 | 1.48e-10 | 1425 | 122 | 24 | 30948266 |
| Pubmed | KRT6A KRT6B PCDHGC4 PCDHGB7 MAP1B SYNE1 KRT84 SPTA1 MYRIP CCDC127 XPC DDX5 PDIA4 UBXN4 KRT6C AP2B1 DNAJC11 SYNE2 ASPM SPEN HSPA2 EPHA4 MYBPC2 | 1.08e-09 | 1442 | 122 | 23 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TPR KRT6B CCDC22 MAP1B PDHA1 POLRMT EXOC3 OAS3 RECQL XPC DDX5 CRNKL1 PELO TCERG1 AP2B1 EIF2B4 RBM14 ASPM AFDN RPA1 DYNC1H1 HDLBP | 1.84e-09 | 1353 | 122 | 22 | 29467282 |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 2.07e-09 | 16 | 122 | 5 | 15085952 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | TPR EPPK1 MAP1B RBM26 RECQL DDX5 EIF3CL PDIA4 PELO AP1B1 TCERG1 AP2B1 EIF2B4 RBM14 AFDN RPA1 HSPA2 DYNC1H1 DNM2 HDLBP | 3.53e-09 | 1149 | 122 | 20 | 35446349 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | TPR KRT4 KRT6A KRT6B EPPK1 PLOD3 RBM26 RECQL DDX5 CRNKL1 GTF2F1 PELO AP1B1 KRT6C TCERG1 AP2B1 SYNE2 EIF2B4 RBM14 UBA6 DYNC1H1 HDLBP | 4.17e-09 | 1415 | 122 | 22 | 28515276 |
| Pubmed | KRT6A KRT6B MAP1B PDHA1 SYNE1 SPTA1 ZNFX1 DDX5 EIF3CL ATP8A1 AP1B1 AP2B1 GNB5 NGEF RBM14 AFDN CROCC PCDH1 HSPA2 DYNC1H1 DNM2 HDLBP | 5.11e-09 | 1431 | 122 | 22 | 37142655 | |
| Pubmed | KRT4 TBC1D15 PLOD3 MAP1B PDHA1 RBM26 POLRMT ATG2A COL18A1 XIRP2 DZIP3 RPA1 DNM2 | 5.18e-09 | 437 | 122 | 13 | 20562859 | |
| Pubmed | CPNE8 TBC1D15 MOSPD2 PLOD3 SYNM PDHA1 SYNE1 POLRMT EXOC3 BCKDHA DICER1 PDIA4 COL18A1 UBXN4 DNAJC11 SYNE2 EIF2B4 ASPM UBA6 SUCO HSPA2 HDLBP | 1.02e-08 | 1487 | 122 | 22 | 33957083 | |
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 1.99e-08 | 84 | 122 | 7 | 29563501 | |
| Pubmed | CPNE8 TBC1D15 CCDC22 PLOD3 MAP1B POLRMT OAS3 RECQL BCKDHA LMBRD2 DICER1 PELO AP2B1 SYNE2 EIF2B4 RBM14 RPA1 HSPA2 RAB27A DYNC1H1 TBP | 2.96e-08 | 1440 | 122 | 21 | 30833792 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | RDH10 EXOC3 BCKDHA E2F4 E2F5 NPHP4 DICER1 DDX5 EIF3CL AP2B1 RABEP1 EIF2B4 RBM14 DZIP3 AFDN EIF2AK1 RPA1 DYNC1H1 DNM2 WDR48 | 3.58e-08 | 1321 | 122 | 20 | 27173435 |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 29357356 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 7543104 | ||
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 4.21e-08 | 3 | 122 | 3 | 1372089 | |
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 1712823 | ||
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 4.21e-08 | 3 | 122 | 3 | 25557232 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CPNE8 MAP1B PDHA1 SPTA1 OGN DDX5 ATP8A1 AP1B1 AP2B1 GNB5 HSPA2 DYNC1H1 DNM2 HDLBP | 4.22e-08 | 621 | 122 | 14 | 22794259 |
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 6.98e-08 | 12 | 122 | 4 | 10692104 | |
| Pubmed | MAP1B POLRMT EXOC3 ZNFX1 LMBRD2 DICER1 GTF2F1 AP1B1 TCERG1 RBM14 STARD3 AFDN DNM2 WDR48 | 7.40e-08 | 650 | 122 | 14 | 38777146 | |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | TPR PLOD3 BRK1 VAT1L EIF3CL AP1B1 AP2B1 RBM14 AFDN RPA1 SPEN HSPA2 DYNC1H1 HDLBP | 9.77e-08 | 665 | 122 | 14 | 30457570 |
| Pubmed | 1.07e-07 | 107 | 122 | 7 | 32989256 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | EPPK1 MAP1B RBM26 POLRMT EXOC3 XPC INO80 AP2B1 UHRF1 RPA1 DNM2 | 1.57e-07 | 394 | 122 | 11 | 27248496 |
| Pubmed | KRT6A KRT6B PLOD3 KRT81 KRT84 KRT86 DDX5 KRT6C AP2B1 HSPA2 DYNC1H1 HDLBP | 1.64e-07 | 488 | 122 | 12 | 31324722 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 15797458 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | TBC1D15 BRK1 PDHA1 PEPD RECQL ARMC9 DDX5 EIF3CL PDIA4 METTL1 GTF2F1 AP1B1 AP2B1 RABEP1 SURF2 UBA6 CROCC RPA1 DYNC1H1 HDLBP | 1.71e-07 | 1455 | 122 | 20 | 22863883 |
| Pubmed | KRT81 L1TD1 CCDC127 XPC FMNL3 TRAF4 AP1B1 UBA6 AFDN PCDH1 DYNC1H1 DNM2 HDLBP | 1.75e-07 | 591 | 122 | 13 | 15231748 | |
| Pubmed | TPR KRT6B EPPK1 ZNFX1 DDX5 PDIA4 GTF2F1 DNAJC11 EIF2B4 RBM14 AFDN DYNC1H1 DNM2 HDLBP | 2.20e-07 | 711 | 122 | 14 | 33022573 | |
| Pubmed | PLOD3 SYNE1 CLK4 RBM26 POLRMT XPC INO80 DICER1 COL18A1 CRNKL1 GTF2F1 UBXN4 TCERG1 DNAJC11 AFDN CROCC ZNF598 SPEN TBP HDLBP | 2.68e-07 | 1497 | 122 | 20 | 31527615 | |
| Pubmed | 2.72e-07 | 75 | 122 | 6 | 31527668 | ||
| Pubmed | KRT6A CPNE8 PDHA1 RBM26 RDH10 OAS3 XPC DICER1 COL18A1 CRNKL1 AP1B1 TCERG1 AP2B1 EIF2B4 RBM14 UHRF1 RPA1 DYNC1H1 HDLBP | 3.18e-07 | 1371 | 122 | 19 | 36244648 | |
| Pubmed | 3.43e-07 | 187 | 122 | 8 | 26460568 | ||
| Pubmed | TPR EPPK1 PLOD3 POLRMT E2F4 XPC AP2B1 PIGR RPA1 HSPA2 DNM2 HDLBP WDR48 | 3.88e-07 | 634 | 122 | 13 | 34591612 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | 4.07e-07 | 344 | 122 | 10 | 30333137 | |
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 20301457 | ||
| Pubmed | 5.10e-07 | 197 | 122 | 8 | 23686814 | ||
| Pubmed | TPR TBC1D15 CCDC22 MAP1B RBM26 TCERG1 RABEP1 AFDN ZNF598 SPEN DYNC1H1 HDLBP | 5.72e-07 | 549 | 122 | 12 | 38280479 | |
| Pubmed | Oct4 links multiple epigenetic pathways to the pluripotency network. | 6.39e-07 | 203 | 122 | 8 | 22083510 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 7490069 | ||
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 8.60e-07 | 91 | 122 | 6 | 34445801 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | EPPK1 SYNE1 RBM26 POLRMT ZNFX1 DDX5 CRNKL1 GTF2F1 TCERG1 RBM14 ZNF598 SPEN DYNC1H1 HDLBP | 9.92e-07 | 807 | 122 | 14 | 22681889 |
| Pubmed | 1.25e-06 | 222 | 122 | 8 | 35941108 | ||
| Pubmed | Frizzled6 deficiency disrupts the differentiation process of nail development. | 1.46e-06 | 7 | 122 | 3 | 23439395 | |
| Pubmed | TPR SYNE1 ZNFX1 AP1B1 AP2B1 RABEP1 SYNE2 NGEF DZIP3 UBA6 AFDN RPA1 DYNC1H1 DNM2 EPHA4 | 1.51e-06 | 963 | 122 | 15 | 28671696 | |
| Pubmed | 1.77e-06 | 57 | 122 | 5 | 31862882 | ||
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 2.27e-06 | 168 | 122 | 7 | 30631154 | |
| Pubmed | SYNM KRT83 SYNE1 MYRIP ZNFX1 XPC CRNKL1 TCERG1 AP2B1 RABEP1 NGEF AFDN ANKRD36 EIF2AK1 HSPA2 DYNC1H1 DNM2 | 2.65e-06 | 1285 | 122 | 17 | 35914814 | |
| Pubmed | EPPK1 PDHA1 PEPD CCDC127 RECQL XPC PDIA4 ASPM RPA1 HOMEZ TBP | 3.00e-06 | 533 | 122 | 11 | 25544563 | |
| Pubmed | PDHA1 RECQL BCKDHA PDIA4 AP1B1 AP2B1 RBM14 RPA1 DYNC1H1 DNM2 HDLBP | 3.05e-06 | 534 | 122 | 11 | 35032548 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 3.61e-06 | 256 | 122 | 8 | 33397691 | |
| Pubmed | TPR EPPK1 PDHA1 KRT81 KRT84 KRT86 PLEKHG2 PDIA4 ARHGAP22 TRAF4 TCERG1 DNAJC11 NGEF DNM2 | 4.31e-06 | 916 | 122 | 14 | 32203420 | |
| Pubmed | TBC1D15 RBM26 EXOC3 UBXN4 AP1B1 TCERG1 AP2B1 EIF2B4 AFDN DYNC1H1 DNM2 | 4.80e-06 | 560 | 122 | 11 | 35241646 | |
| Pubmed | 4.93e-06 | 70 | 122 | 5 | 34255829 | ||
| Pubmed | 4.95e-06 | 189 | 122 | 7 | 31594818 | ||
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | KRT4 KRT6A KRT6B EPPK1 MAP1B KRT86 NPHP4 KRT6C RABEP1 HSPA2 MYBPC2 | 5.13e-06 | 564 | 122 | 11 | 21565611 |
| Pubmed | MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development. | 5.15e-06 | 358 | 122 | 9 | 32460013 | |
| Pubmed | 5.39e-06 | 360 | 122 | 9 | 33111431 | ||
| Pubmed | 5.45e-06 | 33 | 122 | 4 | 26025364 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | TPR EPPK1 SYNE1 DDX5 EIF3CL PDIA4 CRNKL1 TCERG1 AP2B1 RBM14 UHRF1 RPA1 HSPA2 DYNC1H1 | 6.44e-06 | 949 | 122 | 14 | 36574265 |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | KRT6A KRT6B EPPK1 OAS3 DDX5 EIF3CL PDIA4 AP2B1 RBM14 DYNC1H1 MYBPC2 | 6.68e-06 | 580 | 122 | 11 | 35676659 |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 7.48e-06 | 375 | 122 | 9 | 32788342 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EXOC3 DDX5 GTF2F1 ALDH1A2 PELO TCERG1 RABEP1 RBM14 ASPM SPEN HDLBP | 7.59e-06 | 588 | 122 | 11 | 38580884 |
| Pubmed | 7.72e-06 | 284 | 122 | 8 | 29459677 | ||
| Pubmed | TPR TBC1D15 MAP1B EXOC3 DDX5 PDIA4 TCERG1 UBA6 AFDN RPA1 DYNC1H1 HDLBP | 7.79e-06 | 708 | 122 | 12 | 39231216 | |
| Pubmed | RBM26 RECQL DDX5 PDIA4 GTF2F1 AP1B1 TCERG1 AP2B1 RBM14 RPA1 SPEN DYNC1H1 DNM2 HOMEZ HDLBP | 7.80e-06 | 1103 | 122 | 15 | 34189442 | |
| Pubmed | 7.92e-06 | 285 | 122 | 8 | 32838362 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | TPR CCDC22 DDX5 PDIA4 GTF2F1 UBXN4 AP1B1 TCERG1 AP2B1 DNAJC11 HSPA2 DYNC1H1 DNM2 | 9.26e-06 | 847 | 122 | 13 | 35235311 |
| Pubmed | POLRMT EXOC3 OAS3 AP2B1 EIF2B4 RBM14 UHRF1 ZNF598 DYNC1H1 DNM2 HDLBP | 9.31e-06 | 601 | 122 | 11 | 33658012 | |
| Pubmed | 9.66e-06 | 491 | 122 | 10 | 22623428 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | KRT6A MAP1B RECQL XPC INO80 DICER1 PDIA4 RBM14 ZNF598 SPEN HDLBP WDR48 | 9.74e-06 | 724 | 122 | 12 | 36232890 |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22768332 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11118885 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15096578 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11792814 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10550543 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10550545 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28769056 | ||
| Pubmed | Nesprin-1 and nesprin-2 regulate endothelial cell shape and migration. | 1.22e-05 | 2 | 122 | 2 | 24931616 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11336673 | ||
| Pubmed | A missense mutation in the type II hair keratin hHb3 is associated with monilethrix. | 1.22e-05 | 2 | 122 | 2 | 15744029 | |
| Pubmed | Rab27a and MyRIP regulate the amount and multimeric state of VWF released from endothelial cells. | 1.22e-05 | 2 | 122 | 2 | 19270261 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9790766 | ||
| Pubmed | Syne-1 and Syne-2 play crucial roles in myonuclear anchorage and motor neuron innervation. | 1.22e-05 | 2 | 122 | 2 | 17267447 | |
| Pubmed | Nesprins: tissue-specific expression of epsilon and other short isoforms. | 1.22e-05 | 2 | 122 | 2 | 24718612 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24586179 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23662636 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17761684 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 11489919 | ||
| Pubmed | TCR pathway involves ICBP90 gene down-regulation via E2F binding sites. | 1.22e-05 | 2 | 122 | 2 | 15964557 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 31578382 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10866680 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 10953016 | ||
| Pubmed | E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. | 1.22e-05 | 2 | 122 | 2 | 11030352 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 6207530 | ||
| Interaction | KRT25 interactions | 1.46e-09 | 35 | 122 | 7 | int:KRT25 | |
| Interaction | KRT27 interactions | KRT4 KRT6A KRT6B CCDC22 EPPK1 KRT81 KRT83 KRT86 L1TD1 KRT6C RABEP1 TRAF3IP3 | 3.67e-09 | 202 | 122 | 12 | int:KRT27 |
| Interaction | KRT37 interactions | 9.71e-09 | 100 | 122 | 9 | int:KRT37 | |
| Interaction | KRT36 interactions | 1.54e-08 | 74 | 122 | 8 | int:KRT36 | |
| Interaction | KRT28 interactions | 2.29e-08 | 30 | 122 | 6 | int:KRT28 | |
| Interaction | CCDC8 interactions | TPR KRT6A CPNE8 TBC1D15 EPPK1 MAP1B KRT84 EXOC3 DICER1 DDX5 PDIA4 RBM14 UBA6 UHRF1 AFDN RPA1 DYNC1H1 HDLBP | 8.50e-08 | 656 | 122 | 18 | int:CCDC8 |
| Interaction | ZUP1 interactions | 1.06e-07 | 174 | 122 | 10 | int:ZUP1 | |
| Interaction | DDX39B interactions | KRT4 KRT6A KRT6B KRT84 KRT86 E2F4 DDX5 PDIA4 CRNKL1 KRT6C PIGR RBM14 RPA1 DYNC1H1 DNM2 HDLBP | 3.51e-07 | 570 | 122 | 16 | int:DDX39B |
| Interaction | KRT35 interactions | 3.75e-07 | 111 | 122 | 8 | int:KRT35 | |
| Interaction | SIRT7 interactions | TPR EPPK1 MAP1B PDHA1 POLRMT RECQL DICER1 PDIA4 CRNKL1 AP1B1 AP2B1 SYNE2 AFDN SPEN HSPA2 DYNC1H1 DNM2 HDLBP | 5.42e-07 | 744 | 122 | 18 | int:SIRT7 |
| Interaction | KRT38 interactions | 1.04e-06 | 172 | 122 | 9 | int:KRT38 | |
| Interaction | KRT15 interactions | 1.38e-06 | 178 | 122 | 9 | int:KRT15 | |
| Interaction | KRT33B interactions | 1.54e-06 | 93 | 122 | 7 | int:KRT33B | |
| Interaction | KRT26 interactions | 2.10e-06 | 35 | 122 | 5 | int:KRT26 | |
| Interaction | CFTR interactions | TPR KRT6A KRT6B TBC1D15 EPPK1 PLOD3 MAP1B PDHA1 KRT81 KRT84 KRT86 ARMC9 DDX5 PDIA4 GTF2F1 AP1B1 KRT6C AP2B1 EIF2B4 RBM14 HSPA2 DYNC1H1 DNM2 TBP HDLBP | 2.32e-06 | 1480 | 122 | 25 | int:CFTR |
| Interaction | KRT14 interactions | 2.59e-06 | 192 | 122 | 9 | int:KRT14 | |
| Interaction | KRT16 interactions | 3.20e-06 | 197 | 122 | 9 | int:KRT16 | |
| Interaction | GAN interactions | KRT6B MAP1B SYNE1 KRT84 SPTA1 SYNE2 ANKRD36 CROCC RPA1 HSPA2 | 3.27e-06 | 253 | 122 | 10 | int:GAN |
| Interaction | HTT interactions | TPR CPNE8 EPPK1 MAP1B PDHA1 SPTA1 OGN DDX5 ATP8A1 AP1B1 TCERG1 AP2B1 GNB5 RPA1 HSPA2 DYNC1H1 DNM2 TBP HDLBP | 4.23e-06 | 949 | 122 | 19 | int:HTT |
| Interaction | PHTF1 interactions | 5.75e-06 | 20 | 122 | 4 | int:PHTF1 | |
| Interaction | GRB2 interactions | KRT4 KRT6A EPPK1 MAP1B SYNM KRT81 KRT83 KRT86 TCERG1 AP2B1 RBM14 AFDN RPA1 DYNC1H1 DNM2 HOMEZ EPHA4 | 7.26e-06 | 806 | 122 | 17 | int:GRB2 |
| Interaction | KRT19 interactions | 8.52e-06 | 282 | 122 | 10 | int:KRT19 | |
| Interaction | KRT7 interactions | 9.07e-06 | 80 | 122 | 6 | int:KRT7 | |
| Interaction | BAP1 interactions | TPR EPPK1 MAP1B RBM26 RECQL INO80 DDX5 EIF3CL PDIA4 PELO AP1B1 TCERG1 AP2B1 EIF2B4 RBM14 AFDN RPA1 SUCO HSPA2 DYNC1H1 DNM2 HDLBP | 1.20e-05 | 1314 | 122 | 22 | int:BAP1 |
| Interaction | EIF3F interactions | KRT6A KRT6B MAP1B DDX5 EIF3CL KRT6C ZNF598 RPA1 RAB27A WDR48 | 1.30e-05 | 296 | 122 | 10 | int:EIF3F |
| Interaction | LATS1 interactions | KRT4 KRT6A MAP1B CLK4 NPHP4 COL18A1 GTF2F1 KRT6C XIRP2 DNAJC11 RPA1 MYBPC2 | 1.50e-05 | 440 | 122 | 12 | int:LATS1 |
| Interaction | EFNA4 interactions | 1.52e-05 | 239 | 122 | 9 | int:EFNA4 | |
| Interaction | CDC5L interactions | TPR EPPK1 SYNE1 OAS3 DDX5 CRNKL1 PELO AP1B1 DZIP3 MED12L RPA1 SPEN HSPA2 RAB27A DYNC1H1 DNM2 HDLBP | 1.56e-05 | 855 | 122 | 17 | int:CDC5L |
| Interaction | GTF2I interactions | PDHA1 INO80 DDX5 METTL1 AP1B1 AP2B1 RPA1 HSPA2 RAB27A DYNC1H1 HDLBP | 1.69e-05 | 373 | 122 | 11 | int:GTF2I |
| Interaction | ERCC1 interactions | 2.44e-05 | 57 | 122 | 5 | int:ERCC1 | |
| Interaction | CLEC4D interactions | 3.05e-05 | 261 | 122 | 9 | int:CLEC4D | |
| Interaction | KRT20 interactions | 3.97e-05 | 63 | 122 | 5 | int:KRT20 | |
| Interaction | THOC1 interactions | 4.24e-05 | 210 | 122 | 8 | int:THOC1 | |
| Interaction | NUP62 interactions | 4.33e-05 | 273 | 122 | 9 | int:NUP62 | |
| Interaction | HDAC6 interactions | KRT6A KRT6B EPPK1 PDHA1 OAS3 BCKDHA DDX5 EIF3CL PDIA4 PELO AP2B1 RBM14 AFDN RPA1 HSPA2 DYNC1H1 MYBPC2 | 4.46e-05 | 929 | 122 | 17 | int:HDAC6 |
| Interaction | DES interactions | 5.02e-05 | 158 | 122 | 7 | int:DES | |
| Interaction | COLGALT1 interactions | 5.02e-05 | 158 | 122 | 7 | int:COLGALT1 | |
| Interaction | LRRC59 interactions | MOSPD2 PLOD3 PDHA1 SYNE1 BCKDHA XPC USP20 PDIA4 GTF2F1 UBXN4 SYNE2 EIF2B4 ZNF598 RPA1 SUCO HDLBP | 5.10e-05 | 845 | 122 | 16 | int:LRRC59 |
| Interaction | EED interactions | TPR KRT6A TBC1D15 PLOD3 MAP1B DDX5 FMNL3 CRNKL1 TCERG1 AP2B1 PIGR XIRP2 NRK RBM14 UBA6 AFDN CROCC RPA1 SPEN DYNC1H1 DNM2 HDLBP | 5.12e-05 | 1445 | 122 | 22 | int:EED |
| Interaction | PLRG1 interactions | 5.17e-05 | 216 | 122 | 8 | int:PLRG1 | |
| Interaction | FCHO2 interactions | 5.30e-05 | 109 | 122 | 6 | int:FCHO2 | |
| Interaction | ATXN1 interactions | TPR PLOD3 BRK1 RBM26 PEPD VAT1L AP1B1 AP2B1 SYNE2 RBM14 DZIP3 UHRF1 AFDN RPA1 SPEN HSPA2 DYNC1H1 HDLBP | 5.32e-05 | 1039 | 122 | 18 | int:ATXN1 |
| Interaction | DSP interactions | TPR KRT6A PDHA1 CLK4 NPHP4 USP20 AP1B1 ZNF598 RPA1 HSPA2 HDLBP | 5.32e-05 | 423 | 122 | 11 | int:DSP |
| Interaction | EPS15 interactions | 5.89e-05 | 220 | 122 | 8 | int:EPS15 | |
| Interaction | CIRBP interactions | 6.36e-05 | 164 | 122 | 7 | int:CIRBP | |
| Interaction | ABI1 interactions | 6.47e-05 | 223 | 122 | 8 | int:ABI1 | |
| Interaction | KRT13 interactions | 7.50e-05 | 116 | 122 | 6 | int:KRT13 | |
| Interaction | PRKDC interactions | TPR MAP1B NPHP4 DDX5 METTL1 AP1B1 SYNE2 RBM14 DZIP3 UBA6 ZNF598 RPA1 DYNC1H1 HDLBP | 8.12e-05 | 695 | 122 | 14 | int:PRKDC |
| Interaction | RBM6 interactions | 8.64e-05 | 119 | 122 | 6 | int:RBM6 | |
| Interaction | RNF208 interactions | 9.21e-05 | 75 | 122 | 5 | int:RNF208 | |
| Interaction | NHLRC2 interactions | TBC1D15 EPPK1 KRT84 KRT86 PEPD PIGR RPA1 HSPA2 RAB27A DYNC1H1 | 9.59e-05 | 375 | 122 | 10 | int:NHLRC2 |
| Interaction | PEX14 interactions | 9.89e-05 | 237 | 122 | 8 | int:PEX14 | |
| Interaction | ARRB2 interactions | MAP1B USP20 DDX5 ARHGAP22 AP1B1 AP2B1 SYNE2 AFDN EIF2AK1 RPA1 DYNC1H1 | 9.99e-05 | 454 | 122 | 11 | int:ARRB2 |
| Interaction | YAP1 interactions | TPR KRT6A KRT6B TBC1D15 CCDC22 RBM26 DDX5 COL18A1 TCERG1 RABEP1 RBM14 UHRF1 AFDN RPA1 SPEN HSPA2 DYNC1H1 HDLBP | 1.04e-04 | 1095 | 122 | 18 | int:YAP1 |
| Interaction | OBSL1 interactions | TPR KRT6A KRT6B EPPK1 SYNE1 KRT86 DDX5 PDIA4 CRNKL1 SYNE2 RBM14 UHRF1 AFDN SPEN DYNC1H1 HDLBP | 1.10e-04 | 902 | 122 | 16 | int:OBSL1 |
| Interaction | DYNLT1 interactions | 1.11e-04 | 241 | 122 | 8 | int:DYNLT1 | |
| Interaction | WDR5 interactions | TPR KRT6B EPPK1 ZNFX1 E2F4 INO80 DDX5 PDIA4 GTF2F1 DNAJC11 EIF2B4 RBM14 AFDN RPA1 DYNC1H1 DNM2 TBP HDLBP | 1.11e-04 | 1101 | 122 | 18 | int:WDR5 |
| Interaction | ITGA4 interactions | TPR KRT6A BTNL8 PDHA1 DDX5 PELO TCERG1 AP2B1 RBM14 AFDN DYNC1H1 DNM2 | 1.22e-04 | 547 | 122 | 12 | int:ITGA4 |
| Interaction | ERCC4 interactions | 1.33e-04 | 81 | 122 | 5 | int:ERCC4 | |
| Interaction | C11orf98 interactions | 1.44e-04 | 44 | 122 | 4 | int:C11orf98 | |
| Interaction | EPPK1 interactions | 1.54e-04 | 189 | 122 | 7 | int:EPPK1 | |
| Interaction | NEFM interactions | 1.59e-04 | 190 | 122 | 7 | int:NEFM | |
| Interaction | PML interactions | PLOD3 MAP1B PDHA1 SPTA1 OAS3 RECQL E2F4 TCERG1 PIGR DNAJC11 SYNE2 EIF2B4 SLX4IP UHRF1 DNM2 HDLBP | 1.61e-04 | 933 | 122 | 16 | int:PML |
| Interaction | CWC15 interactions | 1.66e-04 | 134 | 122 | 6 | int:CWC15 | |
| Interaction | CHD4 interactions | TPR KRT6A KRT6B PDHA1 KRT83 KRT84 NPHP4 DDX5 CRNKL1 KRT6C RBM14 DZIP3 ZNF598 RPA1 SPEN HDLBP | 1.72e-04 | 938 | 122 | 16 | int:CHD4 |
| Interaction | AATK interactions | 1.81e-04 | 194 | 122 | 7 | int:AATK | |
| Interaction | DROSHA interactions | 1.86e-04 | 87 | 122 | 5 | int:DROSHA | |
| Interaction | HNRNPA1 interactions | KRT6A KRT6B EPPK1 PLOD3 PDHA1 KRT83 RBM26 RECQL DDX5 CRNKL1 GTF2F1 KRT6C RBM14 AFDN RPA1 HSPA2 | 1.87e-04 | 945 | 122 | 16 | int:HNRNPA1 |
| Interaction | USP14 interactions | CCDC22 MAP1B E2F4 DDX5 PELO RBM14 UHRF1 RPA1 HSPA2 DYNC1H1 HDLBP | 1.91e-04 | 489 | 122 | 11 | int:USP14 |
| Interaction | MTCH2 interactions | 2.10e-04 | 413 | 122 | 10 | int:MTCH2 | |
| Interaction | KRT84 interactions | 2.19e-04 | 49 | 122 | 4 | int:KRT84 | |
| Interaction | OR10H1 interactions | 2.19e-04 | 49 | 122 | 4 | int:OR10H1 | |
| Interaction | POU5F1 interactions | TPR L1TD1 XPC INO80 DDX5 COL18A1 TCERG1 RBM14 AFDN RPA1 DYNC1H1 TBP | 2.24e-04 | 584 | 122 | 12 | int:POU5F1 |
| Interaction | NUP93 interactions | 2.36e-04 | 269 | 122 | 8 | int:NUP93 | |
| Interaction | KRT18 interactions | 2.36e-04 | 419 | 122 | 10 | int:KRT18 | |
| Interaction | SRSF11 interactions | 2.39e-04 | 203 | 122 | 7 | int:SRSF11 | |
| Interaction | PRPH interactions | 2.46e-04 | 204 | 122 | 7 | int:PRPH | |
| Interaction | PRPF8 interactions | KRT6A KRT6B EPPK1 MAP1B DDX5 CRNKL1 TCERG1 RBM14 UHRF1 RPA1 SPEN RAB27A DYNC1H1 HDLBP | 2.55e-04 | 776 | 122 | 14 | int:PRPF8 |
| Interaction | SEC62 interactions | TPR MOSPD2 SYNE1 USP20 PDIA4 UBXN4 SYNE2 EIF2B4 AFDN RPA1 SUCO | 2.56e-04 | 506 | 122 | 11 | int:SEC62 |
| Interaction | KCTD13 interactions | KRT6A MAP1B PDHA1 SYNE1 SPTA1 ZNFX1 DDX5 ATP8A1 AP1B1 AP2B1 GNB5 NGEF RBM14 AFDN CROCC PCDH1 HSPA2 DYNC1H1 DNM2 HDLBP | 2.60e-04 | 1394 | 122 | 20 | int:KCTD13 |
| Interaction | OFD1 interactions | 2.65e-04 | 347 | 122 | 9 | int:OFD1 | |
| Interaction | RPN2 interactions | MOSPD2 PDHA1 SYNE1 RECQL PDIA4 FMNL3 UBXN4 SYNE2 RBM14 ZNF598 RPA1 SUCO HSPA2 HDLBP | 2.76e-04 | 782 | 122 | 14 | int:RPN2 |
| Interaction | MCM2 interactions | TPR KRT6B CPNE8 EPPK1 SYNE1 OAS3 E2F4 DDX5 EIF3CL PDIA4 AP2B1 GNB5 RBM14 RPA1 HSPA2 DYNC1H1 TBP | 2.77e-04 | 1081 | 122 | 17 | int:MCM2 |
| Interaction | PSPC1 interactions | CCDC22 PDHA1 DDX5 ARHGAP22 CRNKL1 TCERG1 NGEF RBM14 ZNF598 RPA1 HDLBP | 2.98e-04 | 515 | 122 | 11 | int:PSPC1 |
| Interaction | RAB7A interactions | CPNE8 TBC1D15 MOSPD2 PDHA1 RECQL ATG2A UBXN4 SYNE2 STARD3 ZNF598 RPA1 HSPA2 JAM3 DNM2 HDLBP | 3.01e-04 | 886 | 122 | 15 | int:RAB7A |
| Interaction | CLEC4E interactions | 3.01e-04 | 353 | 122 | 9 | int:CLEC4E | |
| Interaction | CBL interactions | KRT6A KRT6B SYNM PDHA1 KRT84 SPTA1 DDX5 TRAF4 KRT6C RPA1 HSPA2 | 3.03e-04 | 516 | 122 | 11 | int:CBL |
| Interaction | RYK interactions | 3.11e-04 | 212 | 122 | 7 | int:RYK | |
| Interaction | DDB1 interactions | TPR MAP1B POLRMT RECQL XPC INO80 NPHP4 TCERG1 DZIP3 RPA1 DYNC1H1 HDLBP WDR48 | 3.12e-04 | 697 | 122 | 13 | int:DDB1 |
| Interaction | KRT24 interactions | 3.20e-04 | 54 | 122 | 4 | int:KRT24 | |
| Interaction | EXOC4 interactions | 3.20e-04 | 213 | 122 | 7 | int:EXOC4 | |
| Interaction | AR interactions | TPR EPPK1 RBM26 RECQL E2F4 DDX5 CRNKL1 TRAF4 GTF2F1 RBM14 MED12L UHRF1 RPA1 DYNC1H1 TBP WDR48 | 3.22e-04 | 992 | 122 | 16 | int:AR |
| Interaction | KRT8 interactions | KRT6A KRT6B CCDC22 EPPK1 SYNM KRT84 NPHP4 KRT6C RABEP1 HSPA2 | 3.54e-04 | 441 | 122 | 10 | int:KRT8 |
| Interaction | PTGES2 interactions | 3.56e-04 | 100 | 122 | 5 | int:PTGES2 | |
| Interaction | OIP5 interactions | 3.58e-04 | 217 | 122 | 7 | int:OIP5 | |
| Interaction | SHC1 interactions | 3.62e-04 | 362 | 122 | 9 | int:SHC1 | |
| Interaction | SMARCB1 interactions | 3.77e-04 | 364 | 122 | 9 | int:SMARCB1 | |
| Interaction | PRPF3 interactions | 3.99e-04 | 291 | 122 | 8 | int:PRPF3 | |
| Interaction | KRT12 interactions | 3.99e-04 | 24 | 122 | 3 | int:KRT12 | |
| Interaction | TRIP11 interactions | 4.04e-04 | 158 | 122 | 6 | int:TRIP11 | |
| Cytoband | 12q13 | 1.38e-06 | 71 | 122 | 5 | 12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.14e-06 | 423 | 122 | 9 | chr12q13 | |
| Cytoband | 12q13.13 | 3.20e-05 | 67 | 122 | 4 | 12q13.13 | |
| Cytoband | 17q11-q12 | 1.04e-04 | 6 | 122 | 2 | 17q11-q12 | |
| Cytoband | Xp22.1 | 1.46e-04 | 7 | 122 | 2 | Xp22.1 | |
| GeneFamily | Keratins, type II | 3.19e-13 | 27 | 84 | 8 | 609 | |
| GeneFamily | Spectrin repeat containing nuclear envelope family | 1.27e-04 | 4 | 84 | 2 | 1252 | |
| GeneFamily | E2F transcription factors | 5.86e-04 | 8 | 84 | 2 | 982 | |
| GeneFamily | Fibronectin type III domain containing|Sterile alpha motif domain containing|EPH receptors | 1.87e-03 | 14 | 84 | 2 | 1095 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 2.15e-03 | 15 | 84 | 2 | 458 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_top-relative-expression-ranked_1000 | KRT4 KRT6A TBC1D15 MAP1B SYNM VAT1L INO80 OGN GSDMC ALDH1A2 PIGR FER1L4 HSPA2 DNM2 NPAS2 | 3.71e-05 | 772 | 122 | 15 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_J |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 4.08e-05 | 161 | 122 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k5 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_100 | 4.73e-05 | 35 | 122 | 4 | gudmap_kidney_P3_CapMes_Crym_k1_100 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 195 | 122 | 7 | d32716a12014522492becbde1088dc1106308490 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-06 | 195 | 122 | 7 | b913d5df50c88a3a255f516a1aa42419c6701e1e | |
| ToppCell | Severe-Lymphoid-NK-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.21e-06 | 197 | 122 | 7 | d5b94f9f73e9d050245841b19b046242a32c6258 | |
| ToppCell | Severe-Lymphoid-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.26e-06 | 198 | 122 | 7 | 26b6d20527d22ce68067cdaea6b4330cb779f91b | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Club_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.69e-06 | 162 | 122 | 6 | aed15eef32419b8a4e2afdb9776c2bf2802e96f1 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D3|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.89e-06 | 163 | 122 | 6 | 8a4931c9fdaedcf6c319157821d3556cd25fc9e5 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 8.84e-06 | 175 | 122 | 6 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 181 | 122 | 6 | 65eaa9bc1022bcf0c5f0f92c07a2cbbf11f9b59c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-mesothelial_cell-Mesothelium_(PRG4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-05 | 181 | 122 | 6 | eaac7d58117eddfff06b25521efc431c1351d592 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.11e-05 | 182 | 122 | 6 | 111d434b89902ec11fb07f41b8ee1a98f3991b61 | |
| ToppCell | T_cells-Resident_memory_CD8+_T_cells|World / Immune cells in Kidney/Urine in Lupus Nephritis | 1.18e-05 | 184 | 122 | 6 | e04cabff33a8e36967622ec3e5b37b89afa7e148 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 1.33e-05 | 188 | 122 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-05 | 190 | 122 | 6 | da7341a8a423e5fe4d8e733d8e50c10a3318ac1c | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-05 | 190 | 122 | 6 | 42312f7d79fe889397d32910b625793e2535cc26 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-05 | 190 | 122 | 6 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.41e-05 | 190 | 122 | 6 | 682418a7a2096743112eae3790d40e7e600612c0 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.54e-05 | 193 | 122 | 6 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | Control-CD8+_Tem|Control / Disease condition and Cell class | 1.63e-05 | 195 | 122 | 6 | 7503b3e032f95b350a2782d28e4d412a8dc9ebcc | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-05 | 197 | 122 | 6 | 48311c7d85ffabf59fd1685c31c18b3e84a145b5 | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-05 | 197 | 122 | 6 | 92f35ea602489efd29ce3a8a186d1f70d65faf40 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.73e-05 | 197 | 122 | 6 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | Severe_COVID-19-T/NK-NK|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.73e-05 | 197 | 122 | 6 | cc20162892b59e48653981f91fc9a0c27064444d | |
| ToppCell | BAL-Severe-Lymphocyte-T/NK-NK_cell-NK-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.73e-05 | 197 | 122 | 6 | a26dd66a6bd08b46657b3a7c41669e206a8887b3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.78e-05 | 198 | 122 | 6 | fb3965049cb1961de0d2e74370868e46aa5050c8 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.78e-05 | 198 | 122 | 6 | 9f5726aedd1fb132feab717a029fa302306461b5 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 1.83e-05 | 199 | 122 | 6 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 1.83e-05 | 199 | 122 | 6 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-dn_T|ICU-NoSEP / Disease, condition lineage and cell class | 1.83e-05 | 199 | 122 | 6 | 7fb211f803a8b3a2cfa9455386abea08131c6b52 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.89e-05 | 200 | 122 | 6 | c06426f877919bdd267ea2fd7e7973c6619832ae | |
| ToppCell | Calu_3|World / Cell line, Condition and Strain | 1.89e-05 | 200 | 122 | 6 | a549aa08aeefe905653266dae3936094ff55f8e4 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.79e-05 | 137 | 122 | 5 | 761cc0e2b4971e98f6d0691d4575b5cd208b602d | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 7.03e-05 | 156 | 122 | 5 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 7.03e-05 | 156 | 122 | 5 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_bronchial_vessel-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.03e-05 | 156 | 122 | 5 | ff39712c7a2dc1b85c598d5105789aa291dea726 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.92e-05 | 160 | 122 | 5 | 18ae6822915d16699beb9047baeef9b006901a35 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-H_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.92e-05 | 160 | 122 | 5 | 830f17bad94de05612fe6d53d39e42a4b3f3e2f3 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.16e-05 | 161 | 122 | 5 | 2d63b279d9a5132e1c09b03930bf9039036d24a2 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4/8-lo|Lung / Manually curated celltypes from each tissue | 8.16e-05 | 161 | 122 | 5 | a1f10e04836848b1deaf295fae033f54d1572fcd | |
| ToppCell | Healthy_Control-Lymphoid-B-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.64e-05 | 163 | 122 | 5 | d84bd41b4494c7d5c7f88d511bfe481fb12f079d | |
| ToppCell | Healthy_Control-Lymphoid-B|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.64e-05 | 163 | 122 | 5 | 0f723ec2503afa1b3ebb0754972438ffb6e6179d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.69e-05 | 167 | 122 | 5 | 8fede587572d465cb63f7828141a574185bbb819 | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.02e-04 | 169 | 122 | 5 | 0d96c0b4fd26fbc0bf44ff7bed2936eebcc55b74 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.05e-04 | 170 | 122 | 5 | be2a34c70665d8d11332b1a70eda03d77cb7f7dd | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 1.05e-04 | 170 | 122 | 5 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.08e-04 | 171 | 122 | 5 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | NS-critical-LOC-Lymphoid-NK|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.08e-04 | 171 | 122 | 5 | adda76991d9b150bb8ccf3989b7cbbf41843cf0b | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 1.11e-04 | 172 | 122 | 5 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-suprabasal_interpapillary|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 172 | 122 | 5 | 6ece9bb9f31685c918ca4cb7b82cf6ad1cad48af | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-2|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-04 | 173 | 122 | 5 | 0451450605521fecb27a958628870d268adfb023 | |
| ToppCell | mild_COVID-19_(asymptomatic)-gd_T|World / disease group, cell group and cell class (v2) | 1.14e-04 | 173 | 122 | 5 | b6615ff02f5017d7150b1e33b53f8c7a26081a0d | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.17e-04 | 174 | 122 | 5 | 7be0c6248e77f2d0260b852b01e17892f7828f1b | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Ddit4l_(Neurofilament,_Layer4?)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 35 | 122 | 3 | afb8cd52dffd630ffe8e7812874d5fd52e0b6752 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.21e-04 | 175 | 122 | 5 | 1b910c08d2bfbcc77431ee66103e63a11a9d39fe | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_E|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.27e-04 | 177 | 122 | 5 | 946803293a7955116c80f403e99e4093e798ca3f | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 122 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 178 | 122 | 5 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 178 | 122 | 5 | a3176b2b335db22bb0fb71aafa5d7a287809396e | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 1.38e-04 | 180 | 122 | 5 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 1.38e-04 | 180 | 122 | 5 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c11-GNLY|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.41e-04 | 181 | 122 | 5 | 5cecbafc29cc95896e6ccb2c74d9237b9aaece69 | |
| ToppCell | 356C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.41e-04 | 181 | 122 | 5 | be4f35c9eb5b3083acb2264128f095fac1f3da45 | |
| ToppCell | wk_15-18-Hematologic_Lymphocytic-T_&_ILC-ILCP|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.45e-04 | 182 | 122 | 5 | 6bd48c5d60a259719f65cacee4b8135247e78fa9 | |
| ToppCell | Children_(3_yrs)-Immune-enucleated_erythrocyte-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.45e-04 | 182 | 122 | 5 | 3fddadb2ff75013ec6eeb415872667a6bae1da2d | |
| ToppCell | CF-Myeloid-Neutrophil|CF / Disease state, Lineage and Cell class | 1.49e-04 | 183 | 122 | 5 | da43827952e6fdee2ce94648c316182f272b321c | |
| ToppCell | mild-Myeloid-Neutrophils_1|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.53e-04 | 184 | 122 | 5 | 1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5 | |
| ToppCell | droplet-Marrow-nan-18m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-04 | 185 | 122 | 5 | a45756f91b62cf0fac3582786e5868deb8fd8435 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.60e-04 | 186 | 122 | 5 | 71e87c4c755ab607689cb050f5a363cb520a0f53 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 186 | 122 | 5 | 37860daeecd6d412bd3797f30496a56da667fbd1 | |
| ToppCell | Control-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.60e-04 | 186 | 122 | 5 | 7bc939bf4e71bb4c6409b862c1f6c547d775e089 | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 186 | 122 | 5 | 60830822d3de3147816693404fd03392e04c2b8e | |
| ToppCell | droplet-Liver-Hepatocytes-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 186 | 122 | 5 | baebeffdd426ce767190ddefc857cc78e6a58d36 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 187 | 122 | 5 | 46e15419e80bd7180f3171a99d845b01bb635e53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 187 | 122 | 5 | 0d17b07770e4c881a7ca53a5bd42471457d198fb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 187 | 122 | 5 | 69068480f6819a6c8560ecbb05deb156b4055e12 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.64e-04 | 187 | 122 | 5 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Hematopoietic-Megakaryocytic-Megakaryocyte-Mega|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.64e-04 | 187 | 122 | 5 | 9c8b932a15b8b50982cba4cf8db750e257eb9503 | |
| ToppCell | Smart-seq2-bone_marrow_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.69e-04 | 188 | 122 | 5 | 557a0ac069a6ff4e687cac032f64170b9b247165 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.69e-04 | 188 | 122 | 5 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.73e-04 | 189 | 122 | 5 | f1129eb122bbc051457c5545f1a267beb988b0f2 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.73e-04 | 189 | 122 | 5 | 0b012ee301419fa9ccc387c3ff66c2344b349a97 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-hematopoietic_progenitor-common_myeloid_progenitor|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.73e-04 | 189 | 122 | 5 | 56156325cc36b1329bf483f81bb74f371ef15e20 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-keratinocyte|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 189 | 122 | 5 | 7ee9b00a8bd46f2da9218623bb2617b2e585f9d5 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.73e-04 | 189 | 122 | 5 | 98ace332c3c046694c6ade47de8c8bf57ec51271 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 190 | 122 | 5 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-04 | 190 | 122 | 5 | d153a0bdedcd6865e6ee19575234a78b5d859ff1 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.77e-04 | 190 | 122 | 5 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | Severe-Lymphoid-T-NK|Severe / Condition, Lineage, Cell class and cell subclass | 1.77e-04 | 190 | 122 | 5 | 60642de433f84fa2cecd796c3a1a4aab9219d3db | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.77e-04 | 190 | 122 | 5 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | facs-Trachea-24m-Epithelial-airway_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.77e-04 | 190 | 122 | 5 | 576c45a30a4808b47433bc6c2c41396135556c40 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-04 | 190 | 122 | 5 | 719a5cecc3e8001ca9c38165258b5ff9c800713a | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.77e-04 | 190 | 122 | 5 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | 368C-Lymphocytic-NK_cells-NK_cell_D3|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 191 | 122 | 5 | d7920f4a602b50d0ef064eb47001e71939695ed2 | |
| ToppCell | Control-Lymphoid-ILC_A|Control / Disease state, Lineage and Cell class | 1.81e-04 | 191 | 122 | 5 | 1ca73582dc3d28322b5ee841010067589d848acc | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.81e-04 | 191 | 122 | 5 | 2ad34ccd55362db04511c90cf264ae5b93b48dde | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.86e-04 | 192 | 122 | 5 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.86e-04 | 192 | 122 | 5 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | normal-na-Lymphocytic_T-CytoT_GZMK+|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.86e-04 | 192 | 122 | 5 | 7460ce6e2f91bbf940b684f63231db7501ace09f | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.86e-04 | 192 | 122 | 5 | ed1fb700d3e8f00495727d61e164fc0b70274fd0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-CytoT_GZMK+|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.86e-04 | 192 | 122 | 5 | 6779b0294bb058e748e22b795b6a381c4add37e9 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.86e-04 | 192 | 122 | 5 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| Computational | Genes in the cancer module 239. | 4.70e-05 | 120 | 86 | 7 | MODULE_239 | |
| Computational | Genes in the cancer module 68. | 4.99e-05 | 26 | 86 | 4 | MODULE_68 | |
| Computational | Keratin. | 4.99e-05 | 26 | 86 | 4 | MODULE_298 | |
| Drug | mant-GTP | 8.80e-09 | 50 | 122 | 7 | CID000128647 | |
| Drug | plakin | 1.38e-08 | 82 | 122 | 8 | CID000018752 | |
| Drug | al-Badry | 2.09e-08 | 165 | 122 | 10 | CID000004545 | |
| Drug | MK-6 | 1.59e-07 | 24 | 122 | 5 | CID005283547 | |
| Drug | teleocidin B | 3.32e-07 | 123 | 122 | 8 | CID000072425 | |
| Drug | sulfur mustard | 5.08e-07 | 130 | 122 | 8 | CID000010461 | |
| Drug | homocysteine thiolactone | 5.38e-07 | 131 | 122 | 8 | CID000107712 | |
| Drug | AC1L9MJT | 9.60e-07 | 192 | 122 | 9 | CID000448959 | |
| Drug | dictamnine | 2.97e-06 | 6 | 122 | 3 | CID000068085 | |
| Drug | SC-791 | 2.97e-06 | 6 | 122 | 3 | CID010291510 | |
| Drug | DB07328 | 1.68e-05 | 208 | 122 | 8 | CID011840913 | |
| Drug | AC1L1BIT | 1.76e-05 | 60 | 122 | 5 | CID000001457 | |
| Drug | Calix[4]arene | 2.40e-05 | 11 | 122 | 3 | CID000562409 | |
| Drug | 1-2q | 2.63e-05 | 289 | 122 | 9 | CID000011820 | |
| Drug | melicopicine | 2.85e-05 | 2 | 122 | 2 | CID000101253 | |
| Drug | tebuquine | 2.85e-05 | 2 | 122 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 2.85e-05 | 2 | 122 | 2 | CID000460896 | |
| Drug | sulfosuccinimidobiotin | 3.19e-05 | 12 | 122 | 3 | CID000083894 | |
| Drug | trioxane | 4.13e-05 | 13 | 122 | 3 | CID000008081 | |
| Drug | Mal.4 | 4.27e-05 | 72 | 122 | 5 | CID000122821 | |
| Drug | chrysarobin | 4.52e-05 | 37 | 122 | 4 | CID000068111 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A | 4.64e-05 | 176 | 122 | 7 | 6546_UP | |
| Drug | butyrate | KRT4 KRT6A KRT6B POLM KRT81 KRT83 KRT84 KRT86 POLRMT OAS3 BCKDHA KRT6C HSPA2 WDR48 | 6.38e-05 | 767 | 122 | 14 | CID000000264 |
| Drug | AC1Q6PMK | 6.82e-05 | 41 | 122 | 4 | CID000000775 | |
| Drug | Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A | 7.28e-05 | 189 | 122 | 7 | 4271_DN | |
| Drug | Flunixin meglumine [42461-84-7]; Down 200; 8.2uM; PC3; HT_HG-U133A | 7.78e-05 | 191 | 122 | 7 | 4273_DN | |
| Drug | wortmannin from Penicillium funiculosum; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 7.78e-05 | 191 | 122 | 7 | 1023_DN | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; MCF7; HT_HG-U133A | 8.31e-05 | 193 | 122 | 7 | 3908_DN | |
| Drug | AC1L9LMC | 8.46e-05 | 83 | 122 | 5 | CID000448113 | |
| Drug | sulfonamide-3 | 8.51e-05 | 3 | 122 | 2 | CID009847197 | |
| Drug | 3-amino-5-mercapto-1,2,4-triazole | 8.51e-05 | 3 | 122 | 2 | CID002723869 | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 1821_UP | |
| Drug | CAY10397; Down 200; 10uM; PC3; HT_HG-U133A | 9.15e-05 | 196 | 122 | 7 | 7087_DN | |
| Drug | clobestasol propionate | 9.66e-05 | 17 | 122 | 3 | CID000002791 | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.01e-04 | 199 | 122 | 7 | 3205_UP | |
| Drug | dithranol | 1.15e-04 | 18 | 122 | 3 | CID000002202 | |
| Drug | ATBI | 1.15e-04 | 18 | 122 | 3 | CID000505862 | |
| Disease | MONILETHRIX | 6.40e-08 | 3 | 119 | 3 | 158000 | |
| Disease | Beaded hair | 6.40e-08 | 3 | 119 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 6.40e-08 | 3 | 119 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 2.55e-07 | 4 | 119 | 3 | C0546966 | |
| Disease | hair disease (is_implicated_in) | 1.61e-05 | 2 | 119 | 2 | DOID:421 (is_implicated_in) | |
| Disease | level of Sphingomyelin (d32:1) in blood serum | 4.17e-05 | 17 | 119 | 3 | OBA_2045173 | |
| Disease | Pachyonychia congenita syndrome | 9.63e-05 | 4 | 119 | 2 | cv:C0265334 | |
| Disease | Autosomal dominant Emery-Dreifuss muscular dystrophy | 9.63e-05 | 4 | 119 | 2 | cv:CN293514 | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 9.63e-05 | 4 | 119 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 9.63e-05 | 4 | 119 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 9.63e-05 | 4 | 119 | 2 | C1721007 | |
| Disease | Autosomal Recessive Emery-Dreifuss Muscular Dystrophy | 1.60e-04 | 5 | 119 | 2 | C1450051 | |
| Disease | Pachyonychia Congenita | 1.60e-04 | 5 | 119 | 2 | C0265334 | |
| Disease | Autosomal Dominant Emery-Dreifuss Muscular Dystrophy (disorder) | 1.60e-04 | 5 | 119 | 2 | C0410190 | |
| Disease | Emery-Dreifuss muscular dystrophy | 2.39e-04 | 6 | 119 | 2 | cv:C0410189 | |
| Disease | Muscular Dystrophy, Emery-Dreifuss | 2.39e-04 | 6 | 119 | 2 | C0410189 | |
| Disease | X-Linked Emery-Dreifuss Muscular Dystrophy | 3.34e-04 | 7 | 119 | 2 | C0751337 | |
| Disease | lung cancer (implicated_via_orthology) | 5.70e-04 | 9 | 119 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | sphingomyelin measurement | 9.45e-04 | 278 | 119 | 6 | EFO_0010118 | |
| Disease | myopathy (implicated_via_orthology) | 9.69e-04 | 48 | 119 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Emery-Dreifuss muscular dystrophy (implicated_via_orthology) | 1.04e-03 | 12 | 119 | 2 | DOID:11726 (implicated_via_orthology) | |
| Disease | abdominal fat cell number | 1.27e-03 | 198 | 119 | 5 | EFO_0021534 | |
| Disease | Kartagener syndrome (implicated_via_orthology) | 1.42e-03 | 14 | 119 | 2 | DOID:0050144 (implicated_via_orthology) | |
| Disease | Intellectual Disability | 2.29e-03 | 447 | 119 | 7 | C3714756 | |
| Disease | DiGeorge syndrome (implicated_via_orthology) | 2.64e-03 | 19 | 119 | 2 | DOID:11198 (implicated_via_orthology) | |
| Disease | exercise test | 2.92e-03 | 20 | 119 | 2 | EFO_0004328 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 2.99e-03 | 71 | 119 | 3 | EFO_0007878, EFO_0007979 | |
| Disease | reticulocyte count | SPTA1 PEPD GCSAML NLRP6 PELO AP1B1 AP2B1 SYNE2 DZIP3 EIF2AK1 HOMEZ | 3.39e-03 | 1045 | 119 | 11 | EFO_0007986 |
| Disease | Splenomegaly | 3.53e-03 | 22 | 119 | 2 | C0038002 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VYRAKVENEVDRSIQ | 106 | O60637 | |
| RERTEEQKEEYRGRT | 81 | Q96KV6 | |
| RVTRSQEELREDKAY | 1271 | P55196 | |
| YATEVDVDFVRKAVR | 361 | P63010 | |
| GVCRDDVDRRKEYVT | 356 | Q6UX41 | |
| SIYEEFVRRSVERAK | 331 | O94788 | |
| KECRRRGDNLYVVTE | 146 | Q9BYG8 | |
| YATEVDVDFVRKAVR | 361 | Q10567 | |
| RITEEQYRIEADVTK | 1461 | A6QL64 | |
| RAAAEEARRKEEVYK | 461 | O60826 | |
| ERTYDGKVRVTVEVV | 1871 | Q9UPY3 | |
| ASDVRSRSKVVDRIY | 3386 | Q8IZT6 | |
| DLREGVAKAYDTVRE | 1846 | Q2TAZ0 | |
| RTVSEIRSRAEGYEK | 6 | Q9Y2Q0 | |
| VCEEVERVRRSERYQ | 221 | Q9NP87 | |
| RRGRVIECDVVKDYA | 101 | Q96PK6 | |
| TVGIDFREKRVVYRA | 41 | P51159 | |
| QAGEEVTELRRKYTE | 826 | Q5T8P6 | |
| DQKAVYEAVLRSSRA | 301 | P12955 | |
| VLKYREDIINVRTAA | 681 | Q15276 | |
| RADREVAIYSKESII | 311 | O14775 | |
| CNDRSAEYERRVLKE | 1026 | Q9ULG1 | |
| EVERYTINIEAKDRG | 311 | Q9Y5F8 | |
| VSYADVRVERRQELA | 351 | Q99743 | |
| SEDYVELVQRKRVGV | 441 | O60568 | |
| RARIALARAVYQEKE | 731 | Q5T3U5 | |
| VRREASSEELKAAYR | 21 | Q9NVH1 | |
| EVKAQYEEIAQRSRA | 336 | P48668 | |
| EVKAQYEEVARRSRA | 336 | Q9NSB2 | |
| EADAYIREKRESVAS | 981 | P46821 | |
| FGTVRVDRRVIKYEE | 1691 | Q86YW9 | |
| EVKAQYEEIAQRSRA | 336 | P02538 | |
| QLVEAERRSVTYLKR | 216 | Q7Z3E5 | |
| AEIKAQYDDIVTRSR | 276 | O43790 | |
| VSAGRERQDTKERYI | 1276 | A9Z1Z3 | |
| VRAQYEEIAQRSKAE | 311 | P19013 | |
| ARRTAQEVETYRRSK | 66 | P17844 | |
| QEVETYRRSKEITVR | 71 | P17844 | |
| KDQNERSYRIVRTAA | 481 | P54764 | |
| TADEEKCRSIRRQYR | 31 | Q8N140 | |
| ERYKSEDEANRDRVA | 526 | P54652 | |
| EVKAQYEEIAQRSRA | 336 | P04259 | |
| DREQRESYELKVVAA | 571 | Q08174 | |
| QDLYSIVRRADRAAV | 1626 | P39060 | |
| KANDTSYIRDRIEEI | 256 | P20774 | |
| DVQRVYVELKFTVRD | 101 | P54753 | |
| ALYRCEVVARNDRKE | 111 | Q9BX67 | |
| DVRRKNLEIYEAVTS | 516 | Q32M88 | |
| DREKQSDYRLVLTAV | 201 | Q9Y5F7 | |
| TTYIREREGRTKDQI | 461 | P50570 | |
| AKSELRAAIDRYVQE | 296 | Q9UI10 | |
| TDYGETEKERLARQR | 741 | Q86Y13 | |
| DLQVIAAYRERTKAE | 951 | O75161 | |
| EKEVQRLTSRAARDY | 326 | Q86WN1 | |
| IFRVRVKVETYNDES | 571 | P27694 | |
| TRKVRQFRERSETEY | 96 | Q5JQS6 | |
| RVQRYLEEKGTTEEV | 486 | B5ME19 | |
| NFELRYKEVDRARTI | 351 | Q9BZJ0 | |
| RAERDELAIKYNAVS | 101 | Q5TZA2 | |
| ALERRIEYIEARVTK | 56 | Q8WUW1 | |
| AADTLAVRQKRRIYD | 46 | Q16254 | |
| DTLAVRQKRRIYDIT | 81 | Q15329 | |
| EVEKEREAYRRRTAA | 51 | Q96BQ5 | |
| RTKEREEDRCSLNIY | 6 | A6NGG3 | |
| VERNKRGREYVDESA | 396 | Q9BQI3 | |
| RDAKTAEEAYNAVVR | 886 | Q8IVF7 | |
| KRYDERIDRVETRIT | 551 | Q14204 | |
| RTYERTCEKVEERNT | 786 | Q14204 | |
| SEEIEETRARVVYRR | 116 | Q8IX15 | |
| VKNVGRYREAARSEI | 191 | Q9HAZ1 | |
| QYRRREARKKASVEA | 31 | O60645 | |
| ETKNRLEREVYEGRF | 451 | O00411 | |
| AAKLRAVEQRVASYE | 31 | Q8IW40 | |
| DVRVSSRGKYAERDI | 486 | Q86YQ8 | |
| RRAERAYRFVKENET | 366 | P59044 | |
| AEIKAQYDDIATRSR | 281 | P78385 | |
| VYNATKEARRRAVAE | 306 | P12694 | |
| SYVDQRARRAEILSE | 86 | Q9Y6K5 | |
| FEREEAIKEQYTVRR | 346 | Q7Z2Y5 | |
| KLISETRRRFEAEYV | 11 | Q8NHP6 | |
| DVQVTEDAVRRYLTR | 451 | P35269 | |
| ERYRAIQERAKEAVT | 3471 | Q8NF91 | |
| ENLTRYKEAVTRAVE | 3256 | Q8WXH0 | |
| TIARESYRDRRDKVA | 466 | O15061 | |
| KYTRANNRTERDRIE | 636 | Q68DH5 | |
| SEENYRAAIKAERII | 661 | Q5T2S8 | |
| LAAVDVSARAEVRRY | 266 | P58107 | |
| EYRDKSTLQEIETRR | 181 | Q8N5V2 | |
| YEGSRTQEEIVAKVR | 151 | P13667 | |
| RSRYVRLVDSVKENA | 326 | Q9BRX2 | |
| REKATDEGRRETTVY | 206 | Q15527 | |
| YLTAERVRKEVGEVS | 126 | Q8IZV5 | |
| REYIRQGKEATAVVD | 236 | Q14849 | |
| CRQRTEYERSVKRIE | 611 | Q7Z5H3 | |
| KETIDSRVQEYLEVR | 46 | Q5VYV7 | |
| AERTEKVYDRVSVEA | 391 | P37287 | |
| KAYEARRFTRIAVDE | 206 | P46063 | |
| EEEVREALVRSGYKV | 236 | P11086 | |
| YTRTVKLEEVDRGDV | 756 | A4UGR9 | |
| AESYEAKCERRQEIR | 16 | Q9Y228 | |
| TALDNVEARRYVDSR | 566 | A0AVT1 | |
| GRRKVQVSYVIRDEV | 11 | Q8TAF3 | |
| REDVRKNYCSLRDET | 1126 | Q96T58 | |
| YRTREEIQEVRSKSD | 301 | P08559 | |
| FDQYVKTRAEEERRE | 706 | O14776 | |
| REEYERAQKAVASLS | 441 | P12270 | |
| SEEQSRLAARKYARV | 226 | P20226 | |
| VLTRYQSFKERVAER | 31 | P02549 | |
| RKRNYVRDDAVFIRA | 446 | Q9BUZ4 | |
| RNADYVQEVKRISAE | 231 | Q9HCJ6 | |
| RKNVDRVSIRSYRTD | 666 | P01833 | |
| AELKREVSDRQSYLV | 1001 | Q9UBS9 | |
| DYRSLIEKDVNRTDR | 406 | Q8TC07 | |
| RKEQRYRSVISDIFD | 436 | Q9Y2K6 | |
| QEKRREGTLRVDTYT | 306 | Q9P2E3 | |
| YKREEEDREVAAAVR | 336 | Q86UK7 | |
| KRETRTARELYANVV | 246 | Q96T88 | |
| VAREIVETERAYVRD | 106 | Q9H7P9 | |
| YEKNTEAARDAILRI | 1106 | Q00341 | |
| ERRVASRVSYKEESG | 421 | Q01831 | |
| EVKRESYARERSTVA | 306 | Q92575 | |
| KVSDYVQDRIRALRA | 111 | Q9UBP6 | |
| AEIKAQYDDIVTRSR | 276 | Q14533 | |
| EKIIRASRERREITY | 771 | Q5T7N2 | |
| ESAQREDEGRYTIKV | 606 | Q14324 | |
| TDTTEEKRRNRLYEL | 576 | Q8NFW9 |